Literature DB >> 8318481

Subretinal exudative deposits in central serous chorioretinopathy.

D Ie1, L A Yannuzzi, R F Spaide, M F Rabb, N P Blair, M J Daily.   

Abstract

The presence of subretinal exudation in a patient with neurosensory detachment of the macula frequently suggests the diagnosis of choroidal neovascularisation. A retrospective chart review of newly diagnosed cases of central serous chorioretinopathy revealed 11 patients, seven men and four non-pregnant women, who had plaques of subretinal exudate, which presumably were fibrin. Each of these patients had a solitary plaque that ranged in size from 300 to 1500 microns in diameter. These patients had no signs or a clinical course suggestive of choroidal neovascularisation. In each case the subretinal plaque was overlying an exuberant leak in the retinal pigment epithelium. The exudate was generally present at the initial examination, and usually showed dissolution before or coincident with the resolution of the neurosensory detachment. After resolution of the central serous chorioretinopathy, patients were left with subtle alterations in the retinal pigment epithelium in the areas of the subretinal plaque. These findings are important for two reasons. Firstly, the presence of subretinal exudation does not necessarily rule out the diagnosis of central serous chorioretinopathy. Secondly, pathophysiological theories of central serous chorioretinopathy must explain how the plaques are deposited behind the retina.

Entities:  

Mesh:

Year:  1993        PMID: 8318481      PMCID: PMC504528          DOI: 10.1136/bjo.77.6.349

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  'Blow-outs' in the retinal pigment epithelium.

Authors:  B G Goldstein; P R Pavan
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

2.  Pathogenesis of central serous retinopathy: a new working hypothesis.

Authors:  M Spitznas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

3.  Bullous retinal detachment. An unusual manifestation of idiopathic central serous choroidopathy.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1973-05       Impact factor: 5.258

4.  [Histological examination of central serous retinopathy].

Authors:  H Ikui
Journal:  Nihon Ganka Kiyo       Date:  1969-11

5.  Central serous chorioretinopathy and white subretinal exudation during pregnancy.

Authors:  J D Gass
Journal:  Arch Ophthalmol       Date:  1991-05

6.  Experimental serous retinal detachment and focal pigment epithelial damage.

Authors:  A Negi; M F Marmor
Journal:  Arch Ophthalmol       Date:  1984-03

7.  Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy.

Authors:  L A Yannuzzi; J L Shakin; Y L Fisher; M A Altomonte
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

8.  Microrips of the retinal pigment epithelium.

Authors:  D Ie; L A Yannuzzi; R F Spaide; K P Woodward; L J Singerman; M S Blumenkranz
Journal:  Arch Ophthalmol       Date:  1992-10

9.  Central serous chorioretinopathy: some considerations on the pathogenesis.

Authors:  F C Piccolino
Journal:  Ophthalmologica       Date:  1981       Impact factor: 3.250

10.  Retinal vascular loss in idiopathic central serous chorioretinopathy with bullous retinal detachment.

Authors:  K Akiyama; M Kawamura; T Ogata; E Tanaka
Journal:  Ophthalmology       Date:  1987-12       Impact factor: 12.079

View more
  17 in total

1.  [Central serous chorioretinopathy (CSC)].

Authors:  H Baraki; N Feltgen; J Roider; H Hoerauf; C Klatt
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

2.  [Inferior retinal detachment with whitish subretinal lesion].

Authors:  H Helbig; C Valmaggia; H Niederberger
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

3.  Ring-shaped subretinal fibrinous exudate in central serous chorioretinopathy.

Authors:  Masaaki Saito; Tomohiro Iida; Shoji Kishi
Journal:  Jpn J Ophthalmol       Date:  2005 Nov-Dec       Impact factor: 2.447

4.  Alterations in "in vivo" histology of retina in bilateral chronic central serous chorioretinopathy after intravitreal bevacizumab.

Authors:  Sandeep Saxena; Astha Jain
Journal:  J Ocul Biol Dis Infor       Date:  2012-03-08

5.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

6.  Half-dose verteporfin combined with half-fluence photodynamic therapy for chronic central serous chorioretinopathy.

Authors:  Chun-Fu Liu; Lee-Jen Chen; Shawn H Tsai; Chi-Chun Lai; Wei-Chun Chan; Wei-Chi Wu; Nan-Kai Wang; Kuan-Jen Chen; Yih-Shiou Hwang; Yen-Po Chen; Ling Yeung
Journal:  J Ocul Pharmacol Ther       Date:  2014-03-05       Impact factor: 2.671

7.  Subretinal fibrin absorption after 577-nm subthreshold micropulse laser therapy in a CSC case: a brief report.

Authors:  Lijun Zhou; Tao Li; Kunbei Lai; Chuangxin Huang; Fabao Xu; Zhe Zhu; Lin Lu; Chenjin Jin
Journal:  Lasers Med Sci       Date:  2017-09-05       Impact factor: 3.161

8.  Indocyanine green angiography in central serous chorioretinopathy. ICG angiography in CSC.

Authors:  U Menchini; G Virgili; P Lanzetta; E Ferrari
Journal:  Int Ophthalmol       Date:  1997       Impact factor: 2.031

9.  Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.

Authors:  W-M Chan; D S C Lam; T Y Y Lai; B S M Tam; D T L Liu; C K M Chan
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

10.  Efficacy of half-fluence photodynamic therapy depending on the degree of choroidal hyperpermeability in chronic central serous chorioretinopathy.

Authors:  S H Lim; W Chang; M Sagong
Journal:  Eye (Lond)       Date:  2013-03-01       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.